Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials

Direct oral anticoagulants (DOACs) may be good alternatives to low molecular weight heparin (LMWH) or vitamin K antagonists (VKA) for treatment of cancer associated thrombosis (CAT). We conducted a meta-analysis of ten randomized clinical trials to evaluate the efficacy and safety of DOACs in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Ruchi, Koipallil, Gautam Krishna, Thomas, Nelson, Mhaskar, Rahul, Visweshwar, Nathan, Laber, Damian, Patel, Ankita, Jaglal, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642281/
https://www.ncbi.nlm.nih.gov/pubmed/33144679
http://dx.doi.org/10.1038/s41598-020-75863-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642281/
https://www.ncbi.nlm.nih.gov/pubmed/33144679
http://dx.doi.org/10.1038/s41598-020-75863-3

Ejemplares similares